Prof. Yanyan Liu 刘艳艳
Chief Physician, Professor
Department of Integrated Traditional Chinese and Western Medicine Oncology, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of lymphoma, multiple myeloma, gastrointestinal tumors, lung cancer, and other malignant tumors.
Dr. Liu is Deputy Director of Internal Medicine at Henan Cancer Hospital. Dr. Liu earned a medical degree from Henan Medical University in 1994 and a PhD in Internal Medicine from Shanghai Jiao Tong University in 2007, followed by postdoctoral work at the University of Nebraska Medical Center. Dr. Liu leads the Lymphoma Institute at Henan Cancer Research Institute.
Professional roles
- Youth Committee Member, Oncology Branch, Chinese Medical Association
- Youth Committee Member, Oncology Branch, Chinese Medical Doctor Association
- Vice Chair, Lymphoma Committee, Henan Anti-Cancer Association
- Vice Chair, Palliative Care Committee, Zhengzhou Hospital Association
Name order: in Chinese the family name comes first (Liu Yanyan). Papers usually list the name as Yanyan Liu or Liu Y.
Selected publications
92 papers on PubMed matched by name and affiliation; 29 as first or senior author since 2016. Most recent first- or senior-author papers:
- Chin Med J (Engl), 2026 (senior author): Burden of esophageal cancer in China and Asia: A systematic analysis for the Global Burden of Disease Study 2023. PubMed 42980217
- J Evid Based Med, 2026 (senior author): Patterns of Esophageal Cancer Stage at Diagnosis: A Systematic Review of Registry-Based Data. PubMed 42861601
- MedComm (2020), 2026 (senior author): All-Oral PI3Kδ and HDAC Inhibition with Parsaclisib Plus Chidamide and Step-Down Maintenance in Relapsed or Refractory Peripheral T-Cell Lymphoma: A Phase Ib Trial. PubMed 42827632
- Eur J Haematol, 2026 (senior author): Translational Insights From the Molecular Landscape to Precision Therapy in Peripheral T-Cell Lymphoma: Integrating Multi-Omics and Artificial Intelligence. PubMed 42711895
- Cancer Med, 2026 (senior author): Survival Trends and Prognostic Modeling in ALK-Positive Anaplastic Large Cell Lymphoma: A Population-Based Study in the Brentuximab Vedotin Era. PubMed 41792044
- BMC Oral Health, 2026 (first author): Sentinel lymph node biopsy in cT1-2N0 lip squamous cell carcinoma: site-specific diagnostic accuracy, anatomic mapping, and survival impact. PubMed 41668105
- J Evid Based Med, 2025 (senior author): Disease Burden of Gastrointestinal Tumors in China From 1990 to 2021, an Analysis for the Global Burden of Disease Study 2021. PubMed 40974336
- Int J Cancer, 2025 (first author): Pirtobrutinib in Chinese patients with relapsed or refractory B-cell malignancies: A single-arm, open-label, phase 2, multicenter trial. PubMed 40018797
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion